The DOI matches its Crossref record; 241 of the 254 references it cites were found in a registry or an index, and 1 are not checked yet; 3 of the 254 sources its claims cite were checked for support.
The Emerging Hallmarks of Cancer Metabolism
Open accessAbstract
Tumorigenesis is dependent on the reprogramming of cellular metabolism as both direct and indirect consequence of oncogenic mutations. A common feature of cancer cell metabolism is the ability to acquire necessary nutrients from a frequently nutrient-poor environment and utilize these nutrients to both maintain viability and build new biomass. The alterations in intracellular and extracellular metabolites that can accompany cancer-associated metabolic reprogramming have profound effects on gene expression, cellular differentiation and the tumor microenvironment. In this Review, we have organized known cancer-associated metabolic changes into six hallmarks: (1) deregulated uptake of glucose and amino acids, (2) use of opportunistic modes of nutrient acquisition, (3) use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH production, (4) increased demand for nitrogen, (5) alterations in metabolite-driven gene regulation, and (6) metabolic interactions with the microenvironment. While few tumors display all six hallmarks, most display several. The specific hallmarks exhibited by an individual tumor may ultimately contribute to better tumor classification and aid in directing treatment.
Verified 2026-10-09 · 1 reference not checked yet
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review organizes known cancer-associated metabolic changes into six hallmarks: deregulated uptake of glucose and amino acids, opportunistic modes of nutrient acquisition, use of glycolysis/TCA cycle intermediates for biosynthesis and NADPH production, increased demand for nitrogen, alterations in metabolite-driven gene regulation, and metabolic interactions with the microenvironment. The authors argue that while few tumors display all six hallmarks, most display several, and the specific hallmarks exhibited may aid tumor classification and treatment direction.
Key findings
- Cancer cells acquire nutrients through oncogene-driven constitutive uptake: PI3K/Akt signaling promotes GLUT1 expression and translocation and potentiates hexokinase and phosphofructokinase, while c-myc drives glutamine transporter (ASCT2, SN2) and glutaminase (GLS1) expression; Rb loss upregulates ASCT2 and GLS1 via E2F.
- Opportunistic nutrient acquisition allows survival under scarcity: Ras- or c-Src-driven macropinocytosis enables lysosomal degradation of extracellular protein (albumin at 20–30 mg/mL supports KRASG12D MEF proliferation without leucine), and mTORC1 inhibitors enhance this route — rapamycin suppresses proliferation at the tumor margin but enhances it in the poorly vascularized tumor core.
- Proliferating cells divert glycolytic intermediates into biosynthesis: cancer cells may use as much as 50% of glucose-derived carbon for serine biosynthesis, and stepwise oxidation of one-carbon-THF species can produce up to 50% of cellular NADPH; PKM2 (rather than PKM1) predominates in essentially all cancer cells and is inhibited by tyrosine phosphorylation and activated by serine.
- Metabolite-driven gene regulation links metabolism to epigenetics: mutant IDH1/IDH2 produce 2-HG that competitively inhibits α-ketoglutarate-dependent dioxygenases, and SDH/FH loss accumulates succinate/fumarate, all producing hypermethylation phenotypes; lactate accumulation promotes M2 macrophage polarization, angiogenesis, and immune-permissive microenvironments.
Methods
- Narrative review/Perspective synthesizing published literature on cancer metabolism; the authors state they organize known cancer-associated metabolic changes into six hallmarks.
- No primary data, sample, or statistical analysis is reported; evidence is drawn from cited studies across cell lines, mouse models, patient samples, and clinical imaging (e.g., 18F-FDG and 18F-glutamine PET).
- Not stated in the paper for any systematic search strategy, inclusion criteria, or quantitative synthesis.
Limitations
- The paper states that most studies to date have focused on glucose and glutamine metabolism, and that the contributions of other nutrients (sulfur-containing amino acids, essential fatty acids, choline, trace metals, vitamins, and microbiota-derived metabolites) are only beginning to be understood.
- The paper notes that cell lineage context and potential secondary effects of adaptation to tissue culture conditions may influence findings such as the choice of anaplerotic substrate (glutamine vs. glucose-derived pyruvate carboxylation).
- Evident from the text: as a narrative review without primary data or systematic methodology, the six-hallmark framework is an organizing proposal rather than an empirically validated classification, and the authors state that few tumors display all six hallmarks.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
161 Not checked yet · 73 No basis given · 48 Own interpretation · 1 Supported · 1 Partly supported · 1 Sources not found · accuracy not yet measured
Every source the paper cites for this claim was checked and supports it.
In the paper
“expression of mutant Ras or c-Src alleles provides cells with a mechanism that allows them to recover free amino acids through the lysosomal degradation of extracellular proteins”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Supportedcites Commisso et al., 2013 source
The paper reports that degradation of extracellular albumin in oncogenic Ras-expressing cells depends on lysosomal hydrolases and yields intracellular amino acids. It also reports that cells expressing constitutively active Src internalize and degrade extracellular albumin, which can augment their amino acid supply. The indexed passages are labeled Abstract; no page number is provided. (LLM, conf=0.91)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tumorigenesis is dependent on the reprogramming of cellular metabolism as both direct and indirect consequence of oncogenic mutations.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
In the paper
“In such a manner, intracellular glutamine may facilitate the import of a broad range of LAT1 substrates, including leucine, isoleucine, valine, methionine, tyrosine, tryptophan and phenylalanine”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Yanagida et al., 2001 source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“when deprived of growth factors, hematopoietic and neuronal cells fail to consume glucose in quantities sufficient to even maintain cellular bioenergetics”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“the optimal growth of cultured HeLa cells requires a 10- to a 100-fold molar excess of glutamine in culture medium relative to other amino acids”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Eagle, 1955 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Thus, glutamine provides the nitrogen required for the biosynthesis of purine and pyrimidine nucleotides, glucosamine-6-phosphate, as well as non-essential amino acids.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“glutamine was found to be the most rapidly consumed amino acid by Ehrlich ascites carcinomas as well as by a number of hepatomas and carcinosarcomas proliferating in vivo”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Marquez et al., 1989 source
- Not checked yetcites Sauer et al., 1982
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Glutamine, a second principal growth-supporting substrate contributes not only carbon, but also reduced nitrogen for the de novo biosynthesis of a number of diverse nitrogen-containing compounds.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“numerous tumorigenic contexts are associated with the depletion of glutamine from the tumor environment as compared to the corresponding normal tissue”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The alterations in intracellular and extracellular metabolites that can accompany cancer-associated metabolic reprogramming have profound effects on gene expression, cellular differentiation and the tumor microenvironment.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
- It may state two separate claims as one. 87
- Probably not a substantial claim. 15
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Increased lactate levels promote the emergence of an immune-permissive microenvironment by attenuating dendritic and T cell activation and monocyte migration (Fischer et al., 2007; Goetze et al., 2011; Gottfried et al., 2006).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Partly supportedcites Fischer et al., 2007 sourceExperimental — accuracy not yet measured
The Discussion reports that lactic acid suppresses human cytotoxic T-cell functions and says earlier work found altered antigen presentation by monocyte-derived dendritic cells. Our copy does not establish reduced dendritic-cell activation or impaired monocyte migration. It also distinguishes lactic acid from sodium lactate, which did not suppress T-cell functions. (LLM, conf=0.88)
- Not checked yetcites Goetze et al., 2011
- Partly supportedcites Gottfried et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion reports that lactic acid inhibits dendritic-cell antigen presentation and reduces IL-12 secretion; the section on phenotypical characterization reports concentration-dependent inhibition of T-cell proliferation during stimulation by dendritic cells. These findings support an immune-suppressive effect, but our copy does not establish that lactate impairs monocyte migration. Its figure on monocyte infiltration does not attribute an impairment to lactate. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
In the paper
“This observation has been confirmed in a variety of tumor contexts and shown to correlate with poor tumor prognosis”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Som et al., 1980
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“tumorigenesis-associated metabolic alterations encompass all stages of cell-metabolite interaction, (a) affecting the metabolite influx through conferring an increased ability to acquire the necessary nutrients; (b) shaping the way the nutrients are preferentially assigned to metabolic pathways that contribute to cellular tumorigenic properties, as well as (c) exerting long-ranging effects on”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INTRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Normally, despite being surrounded by nutrient-rich plasma and the extracellular fluid, metazoan cells do not import nutrients in a constitutive manner. On the contrary, nutrient uptake is strictly regulated by growth factor signaling”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Thompson, 2011 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“controlled oxidation of carbon skeletons of glucose and glutamine allows a cell to capture their reducing power either in the form of NADH and FADH2, which mediate the transfer of electrons to the electron transport chain to fuel ATP generation, or in the form of a related cofactor NADPH, which provides reducing power for a wide variety of biosynthetic reactions, as well as helps maintain cellular”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Positron emission tomography (PET)-based imaging of the uptake of a radioactive fluorine-labeled glucose analog, 18F-fluorodeoxyglucose (18F-FDG) has been successfully used in the clinic for tumor diagnosis and staging, as well as for monitoring responsiveness to treatment”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Almuhaideb et al., 2011
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“This, in turn, negatively affects cell size, mitochondrial potential and ATP generation – all despite the abundance of glucose in the culture medium”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Rathmell et al., 2000
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In order to fulfill the biosynthetic demands associated with proliferation, a cell must increase the import of nutrients from the environment.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Two principal nutrients that support survival and biosynthesis in mammalian cells are glucose and glutamine.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“mTORC1 inhibitors greatly increase the cellular ability to recover amino acids from captured extracellular protein and enhance their growth in the absence of essential amino acids”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Not checked yetcites Palm et al., 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“free amino acids can be recovered from the engulfment and digestion of entire living cells via a process known as entosis (Figure 3B), as well as from phagocytosis of apoptotic cellular corpses”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Not checked yetcites Krajcovic et al., 2013 source
- Not checked yetcites Stolzing and Grune, 2004
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“c-myc induces the transcription of glutamine transporters ASCT2 and SN2, and in addition, promotes expression of glutamine-utilizing enzymes glutaminase (GLS1), phosphoribosyl pyrophosphate synthetase (PRPS2) and carbamoyl-phosphate synthetase 2 (CAD)”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Eberhardy and Farnham, 2001
- Not checked yetcites Gao et al., 2009 source
- Not checked yetcites Mannava et al., 2008
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“While rapamycin suppresses cancer cell proliferation at the tumor margin where the vascular delivery of nutrients is effective, rapamycin enhances cell proliferation within the poorly-vascularized tumor core by promoting enhanced lysosomal degradation of extracellular proteins”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Not checked yetcites Palm et al., 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“subsequent investigations into the mitochondrial status of tumor cells have shown that by and large, tumor cells possess functional mitochondria and retain the ability to conduct oxidative phosphorylation.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, KRAS-mutant cells may not only have a nutritional advantage over their non-mutant neighbors, but also actively eliminate the latter.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“exogenous expression of a constitutively active form of Akt alone can stimulate glycolysis and is sufficient to restore cell size, viability, mitochondrial potential and ATP levels in growth factor-deprived cells in a manner that is dependent upon the presence of glucose in the culture medium”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Plas et al., 2001
- Not checked yetcites Rathmell et al., 2003 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These observations suggest that, rather than being an adaptation to a defect in respiration, the Warburg effect is a regulated metabolic state and may, in fact, be beneficial during a time of increased biosynthetic demand.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Culturing mammary epithelial cells under conditions where the cells are detached from the extracellular matrix compromises glucose uptake and results in a depressed mitochondrial potential and decreased ATP levels”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Grassian et al., 2011
- Not checked yetcites Schafer et al., 2009 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Akt potentiates the activity of the hexokinase (HK), which phosphorylates glucose molecules, thus preventing their efflux back into the extracellular space, as well as of the phosphofructokinase (PFK) enzyme, which catalyzes the key irreversible step of glycolysis”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Deprez et al., 1997
- Not checked yetcites Gottlob et al., 2001
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Other oncogenic signaling proteins - notably, Ras, have been found to upregulate GLUT1 mRNA expression and increase cellular glucose consumption”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Murakami et al., 1992
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, the utilization of extracellular protein as nutrients is repressed by mTORC1 under amino acid-replete conditions and is only utilized as an emergency source in conditions when free amino acids are insufficient.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“generation of palmitic acid consumes 14 reducing equivalents, while building a cholesterol molecule requires 26”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Lunt and Vander Heiden, 2011 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the 18F-FDG-PET signal intensity in tumors correlates closely with the level of PI3K/Akt pathway activity, and is attenuated by PI-3 kinase and receptor tyrosine kinase inhibitors”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Benz et al., 2011
- Not checked yetcites Lheureux et al., 2013
- Not checked yetcites Ma et al., 2009
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In contrast to the effect of KRASG12D, PI3K/Akt signaling does not promote cellular utilization of extracellular protein, despite the ability of this pathway to stimulate the uptake of low molecular weight nutrients”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF OPPORTUNISTIC MODES OF NUTRIENT ACQUISITION
What the sources say
- Not checked yetcites Palm et al., 2015
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“PI3K/Akt signaling promotes both the expression of glucose transporter GLUT1 mRNA and the translocation of GLUT1 protein from the endomembranes to the cell surface”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > DEREGULATED UPTAKE OF GLUCOSE AND AMINO ACIDS
What the sources say
- Not checked yetcites Barthel et al., 1999
- Not checked yetcites Wieman et al., 2007
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A designated donor of reducing equivalents that is used in cellular biosynthetic reactions is NADPH.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A first committed step of hexosamine biosynthesis is a glutamine fructose-6-phospate aminotransferase 1 (GFPT1)-catalyzed production of glucosamine-6-phosphate from fructose-6-phosphate and glutamine.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“A rate-limiting serine biosynthesis enzyme, 3-phosphoglycerate dehydrogenase (PHGDH), is frequently focally amplified in breast cancer and melanoma and is required for the growth of PHGDH-amplified cells in vitro as well as in vivo”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In contrast to the proliferating bulk of a tumor, accumulating evidence suggests that quiescent subpopulations of tumor cells are markedly less glycolytic and exhibit higher dependence on oxidative phosphorylation, as well as elevated expression of mitochondrial respiratory components.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites LeBleu et al., 2014
- Not checked yetcites Viale et al., 2014 source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glycolytic intermediates leave glycolysis to take part in diverse biosynthetic reactions; accordingly, the rate-limiting enzymes within branching pathways of glycolysis are frequently upregulated in tumors.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“While the de novo biosynthesis of fatty acids is low in normal adult tissues – with the exception of lipogenic tissues such as liver, adipose tissue or mammary epithelium in the period of lactation, tumorigenesis is associated with a dramatic increase in lipid production (Li and Cheng, 2014; Menendez and Lupu, 2007).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Li and Cheng, 2014
- Not checked yetcites Menendez and Lupu, 2007
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“By using FAD as an electron acceptor, the mGPDH-catalyzed reaction reduces net mitochondrial electrical chemical potential from NADH generated via glycolysis.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, increased ROS levels facilitate the activation of HIF1α and NRF2 transcription factors, thus promoting transcriptional programs that further contribute to tumorigenesis (Bertout et al., 2008; Sporn and Liby, 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Bertout et al., 2008
- Not checked yetcites Sporn and Liby, 2012 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“First in the series of these branching pathways is the pentose phosphate pathway (PPP), in which glucose-6-phosphate becomes partially oxidized to generate NADPH and ribose-5-phosphate – a structural component of nucleotides.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By converting excess pyruvate to lactate, proliferating cells prevent accumulation of cytosolic NADH and reduce ATP production promoting continued cytosolic glucose metabolism free from feedback repression by excess mitochondrial ATP generation.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The key enzymes in the pathway, transketolase-like 1 (TKTL1) and transaldolase (TALDO) are frequently overexpressed in cancer”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Wang et al., 2011a
- Not checked yetcites Xu et al., 2009b
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“This step is regulated by pyruvate kinase (PK), an enzyme that converts phosphoenolpyruvate to the final product of glycolysis, pyruvate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Any excess glycolytic flux not utilized for biosynthesis is preferentially converted to lactate to help preserve a sufficient pool of NAD+ to sustain glycolysis and avoid flooding the mitochondria with a supply of NADH that would suppress the TCA cycle.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“To this end, ROS act as inhibitors of protein phosphatases such as PTEN and PTP1B, as well as activators of Src family kinases and MAPK (Denu and Tanner, 1998; Kamata et al., 2005; Lee et al., 2002; Yan and Berton, 1996).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Denu and Tanner, 1998
- Not checked yetcites Kamata et al., 2005 source
- Not checked yetcites Lee et al., 2002
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“DHAP is converted by glycerol-3-phosphate dehydrogenase 1 (GPD1) into glycerol-3-phosphate, which is utilized in the biosynthesis of diverse phospholipids, a major structural component of cellular membranes.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“wild-type, but not the mutant, p53 inhibits PPP by directly binding and inactivating the rate-limiting PPP enzyme glucose-6-phosphate dehydrogenase (G6PD)”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Jiang et al., 2011
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Thus, PKM2 is inhibited by tyrosine phosphorylation and activated by serine (Chaneton et al., 2012; Christofk et al., 2008b; Ye et al., 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Chaneton et al., 2012
- Not checked yetcites Christofk et al., 2008b
- Not checked yetcites Ye et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“While PKM1 is more efficient at producing pyruvate, the majority of proliferating cells and essentially all cancer cells express primarily the PKM2 variant”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Christofk et al., 2008a
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Though glycolysis is classically depicted as a single chain of molecular events that leads to the generation of pyruvate, a number of glycolytic intermediates can be diverted into branching pathways, generating diverse biosynthetic precursors.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Through the generation of N-acetylglucosamine (GlcNAc), a substrate for N- and O-linked glycosylation, the hexosamine pathway provides substrates for cellular glycosylation reactions as well as heparan sulfate and hyaluronic acid biosynthesis, potentiates receptor-mediated signaling and regulates the stability of select proteins, including c-myc”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Itkonen et al., 2013
- Not checked yetcites Spiro, 2002
- Not checked yetcites Wellen et al., 2010
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Among such populations are stem-like subclones that emerge following the oncogene ablation in vivo, as well as circulating tumor cells (CTCs) (LeBleu et al., 2014; Viale et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites LeBleu et al., 2014
- Not checked yetcites Viale et al., 2014 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In support of this paradigm, a reintroduction of the PKM1 isoform compromises cancer cell proliferation and tumorigenesis in vivo, in part by negatively affecting serine-dependent biosynthesis (Ye et al., 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Ye et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“while the acetyl-CoA serves as a precursor for lipid biosynthesis and protein acetylation.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, c-myc not only facilitates glutamine uptake, but also promotes its utilization in the biogenesis of purine and pyrimidine bases.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, activity of CAD enzyme is regulated via phosphorylation by MAPK and by mTORC1-dependent S6 kinase (Ben-Sahra et al., 2013; Graves et al., 2000; Robitaille et al., 2013).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A non-essential amino acid containing two atoms of reduced nitrogen, glutamine serves as the principal way in which reduced nitrogen is transported between cells in metazoan organisms.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Thus, one glutamine molecule is used in the production of uracil and thymine, cytosine and adenine each require two, and building a guanine base costs a cell three molecules of glutamine.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In addition to being utilized for nucleotide biosynthesis, glutamine can be directly deamidated to glutamate by glutaminase which is frequently upregulated in cancer cells in a c-myc-dependent manner.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“ASNS is frequently upregulated in tumors and is associated with poor prognosis (Sircar et al., 2012; Zhang et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
What the sources say
- Not checked yetcites Sircar et al., 2012
- Not checked yetcites Zhang et al., 2014 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Imported acetate is converted to acetyl-CoA in a reaction catalyzed by acetyl-CoA synthetase 2 (ACSS2), which is a target for amplification in breast cancer.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In fact, all three major components involved in fatty acyl chain biosynthesis – ACLY, ACC and FASN – are frequently upregulated in transformed cells; furthermore, their inhibition reduces tumor cell growth in vitro and in vivo (Chajes et al., 2006; Flavin et al., 2010; Migita et al., 2008; Milgraum et al., 1997).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These reports highlight that the cell lineage context, as well as potential secondary effects associated with the adaptation of cells to tissue culture conditions may play an important role in the choice of an anaplerotic substrate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In a process referred to as reductive carboxylation, a section of the TCA cycle reverses itself, converting α-ketoglutarate into citrate, which can be then used to generate a source of cytosolic acetyl-CoA (Metallo et al., 2012; Wise et al., 2011).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Glutamine can be captured in mitochondria by glutaminase and the resulting glutamate converted into α-ketoglutarate by either glutamate dehydrogenase or amino acid transaminases.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“An increased capacity for the producing lipids de novo not only facilitates the formation of lipid bilayers, but also enables a cell to alter its membrane composition in favor of oxidative damage-resistant saturated fatty acids as means of adapting to oxidative stress (Rysman et al., 2010).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Rysman et al., 2010
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A carrier of four nitrogen atoms, arginine serves as a precursor for a wide variety of nitrogenous compounds, among which are polyamines, creatine, agmatine and pyrroline-5-carboxylate, a precursor for the biosynthesis of proline.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Moreover, PC inhibition in NSCLC-derived cell lines suppresses fatty acid biosynthesis and dramatically reduces proliferation even in the presence of ample glutamine (Sellers et al., 2015).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
- Not checked yetcites Sellers et al., 2015
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, hypoxia-associated deficit of acetyl-CoA can be augmented not only through the reductive carboxylation of α-ketoglutarate, but also by increasing the utilization of free acetate from plasma and interstitial fluid.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In c-myc-transformed cells in particular, glutamine deprivation leads to the collapse of the TCA cycle and triggers cell death, which can be rescued by the addition of oxaloacetate or a membrane-permeable form of α-ketoglutarate (Wise et al., 2008; Yuneva et al., 2007).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > USE OF GLYCOLYSIS/TCA CYCLE INTERMEDIATES FOR BIOSYNTHESIS AND NADPH PRODUCTION
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Polyamine levels increase in proliferating cells; moreover, polyamines have been shown to inhibit apoptosis and promote tumor growth and invasion (Casero and Marton, 2007; Gerner and Meyskens, 2004).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
What the sources say
- Not checked yetcites Casero and Marton, 2007
- Not checked yetcites Gerner and Meyskens, 2004
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“One possibility is that the inactivation of ASL and ASS1 allows cancer cells to accumulate ornithine, which is then utilized in the production of polyamines, a class of nitrogen-containing polycationic aliphatic carbon molecules.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“For instance, sirtuins, a class of deacetylases that catalyze the removal of acetyl marks from histone and non-histone proteins, utilize NAD+ as a cofactor, while FAD serves as a cofactor for a lysine-specific demethylase LSD1 (Imai et al., 2000; Shi et al., 2004).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Reciprocally, proline oxidase (POX), which mediates proline degradation, is negatively controlled by c-myc via miR-23b, and is a p53 target as well (Donald et al., 2001; Liu et al., 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
What the sources say
- Not checked yetcites Donald et al., 2001
- Not checked yetcites Liu et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Among α-ketoglutarate-dependent dioxygenases are a TET family of DNA demethylases, Jumonji C family of histone demethylases, mRNA demethylases FTO and ALKBH5, and a family of prolyl hydroxylase (PHD) enzymes, which, among other processes, regulate HIF1α levels in response to oxygen availability and oxidative stress.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Argininosuccinate, in turn, is produced by the enzyme argininosuccinate synthase (ASS1) from citrulline and aspartate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“SAM is a product of the one-carbon metabolic pathway and is fueled by serine catabolism as described above.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Tumors that exhibit SDH- and FH loss share a number of phenotypic features that are consistent with dioxygenase inhibition, among which is a characteristic global increase in DNA methylation (Killian et al., 2013; Letouze et al., 2013; Xiao et al., 2012), as well as elevated levels of HIF1α (Selak et al., 2005).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Proline can be produced either from glutamate or from arginine-derived ornithine via a common intermediate, pyrroline-5-carboxylate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Indeed, withdrawal and readdition of glucose, as well as activation of oncogenic signaling via introduction of an oncogenic KRAS mutant or a constitutively active form of Akt, increase total histone acetylation, which, in turn, promotes the enhanced and broader gene expression (Lee et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
- Not checked yetcites Lee et al., 2014 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The de novo biosynthesis of arginine is an integral part of the urea cycle, where it is derived from argininosuccinate in a cleavage reaction catalyzed by argininosuccinate lyase (ASL).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > INCREASED DEMAND FOR NITROGEN
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The deposition of acetyl marks on histones is associated with the increased accessibility of the genomic DNA for the assembly of transcriptional complexes, and has a rapid turnover rate.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“As discussed earlier, tumors are often faced with nutrient- and oxygen-poor surroundings and develop various nutrient-scavenging strategies to bypass these limitations.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Furthermore, hypoxia impedes the ability of cells to carry out oxidative phosphorylation and other reactions that require oxygen and disrupts the redox balance, affecting cellular signaling and transcriptional programs.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“a gasotransmitter with complex and not yet fully defined functions in cellular physiology, among which are protection from oxidative stress, increased mitochondrial respiration, protection from apoptosis and facilitation of angiogenesis (Wu et al., 2015).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
What the sources say
- Not checked yetcites Wu et al., 2015
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Oncogene-driven metabolic reprogramming allows cancer cells to maintain deregulated proliferation, withstand metabolic challenges that are associated with oxygen and nutrient limitations, maintain a dedifferentiated state through alterations in global patterns of gene expression, and corrupt the surrounding microenvironment into actively assisting tumor growth and dissemination.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Increased extracellular acidification stimulates the proteolytic activity of matrix metalloproteinases (MMPs) and cathepsins, promoting the degradation of the extracellular matrix components and enhancing tumor invasion (Martinez-Zaguilan et al., 1996; Rothberg et al., 2013).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Martinez-Zaguilan et al., 1996
- Not checked yetcites Rothberg et al., 2013
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Thus, cancer cells upregulate the uptake of cysteine via the transcriptional upregulation of the xCT transporter, as well as secondary to the increased rate of glutamine utilization by cells (Lo et al., 2008).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
What the sources say
- Not checked yetcites Lo et al., 2008
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Thus, lactate promotes the stabilization of HIF1α and activates NF-κB and PI-3 kinase signaling in endothelial cells, as well as induces secretion of a pro-angiogenic factor VEGF from tumor-associated stromal cells (Constant et al., 2000; Schmid et al., 2007; Sonveaux et al., 2012; Vegran et al., 2011).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Constant et al., 2000 source
- Not checked yetcites Schmid et al., 2007
- Not checked yetcites Sonveaux et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“How cancer cells reprogram their microenvironment to assist tumor growth and dissemination is an area of intense investigation, but it is clear that such reprogramming encompasses multiple strategies, among which are secreted growth factors and alterations to the extracellular matrix and cell-cell interactions.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition, a specific increase in the L enantiomer of 2-HG, which was shown to exert similar, but not identical, inhibitory effects on α-ketoglutarate-dependent dioxygenases was found in clear cell renal cell carcinoma, where it correlates with increased methylcytosine levels (Shim et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
- Not checked yetcites Shim et al., 2014 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Increased choline uptake is observed in breast and prostate cancer; in fact, radioactive 18F- and 11C-choline is used in the clinic for PET-based tumor imaging (Krause et al., 2013; Kwee et al., 2007).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
What the sources say
- Not checked yetcites Krause et al., 2013
- Not checked yetcites Kwee et al., 2007
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In various cellular settings, ectopic expression of a mutant IDH allele or treatment with exogenous D-2-HG is sufficient to induce DNA and histone hypermethylation and block cellular differentiation (Losman et al., 2013; Lu et al., 2012).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
- Not checked yetcites Losman et al., 2013 source
- Not checked yetcites Lu et al., 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Increased levels of lactate also stimulate hyaluronic acid production by fibroblasts, which may contribute to tumor invasiveness (Stern et al., 2002).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Stern et al., 2002
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Specifically, numerous solid tumor types overexpress tryptophan-degrading dioxygenases indoleamine-2, 3-dioxygenase (IDO1) and tryptophan-2, 3-dioxygenase (TDO2), which catalyze the conversion of an essential amino acid, tryptophan, into its derivative, kynurenine (Munn and Mellor, 2007).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Munn and Mellor, 2007
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In addition, lactate stimulates the polarization of resident macrophages to a so-called M2 state, which plays a role in immunosuppression and wound healing (Carmona-Fontaine et al., 2013; Colegio et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Carmona-Fontaine et al., 2013
- Not checked yetcites Colegio et al., 2014 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Finally, kynurenine potentiates autocrine signaling through AhR on cancer cells themselves, promoting the degradation of the extracellular matrix and invasion (Opitz et al., 2011).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Opitz et al., 2011
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“While most of the studies to this point have been focused on alterations in the metabolism of glucose and glutamine, cancer cells utilize a great variety of other nutrients, among which are sulfur–containing amino acids cysteine and methionine, essential fatty acids, choline, trace metals, and vitamins.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“IDH mutations in AML are mutually exclusive with inactivating mutations in TET2 methylcytosine hydroxylases, further implicating mutant IDH as a bona fide driver of epigenetic remodeling (Figueroa et al., 2010).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > ALTERATIONS IN METABOLITE-DRIVEN GENE REGULATION
What the sources say
- Not checked yetcites Figueroa et al., 2010 source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In a manner that is dependent on AhR, kynurenine promotes regulatory T-cell phenotype, further contributing to the suppression of antitumor immune responses (Fallarino et al., 2006).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > METABOLIC INTERACTIONS WITH THE MICROENVIRONMENT
What the sources say
- Not checked yetcites Fallarino et al., 2006
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Micronutrients are utilized as cofactors for various enzymes and play complex and not yet fully defined roles in regulating cellular metabolic circuits, as well as signal transduction.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, copper was recently shown to be required for BRAFV600E-driven ERK activation in melanoma cells, and the effect of copper depletion could be rescued by the constitutive activation of ERK (Brady et al., 2014).”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
What the sources say
- Not checked yetcites Brady et al., 2014
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As many cancers are characterized by increased methylation of CpG islands, alterations in ascorbic acid import may thus affect their epigenetic state as well.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“For instance, ascorbic acid acts as a cofactor for the α-ketoglutarate-dependent dioxygenases.”
§ THE EMERGING HALLMARKS OF CANCER METABOLISM > REMAINING QUESTIONS
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
Most tumors display several of the six metabolic hallmarks, while few display all six.
“While few tumors display all six hallmarks, most display several.”
The paper relies on this without support.
Findings from animal models about dietary methyl donors and epigenetic marks apply to human tumorigenesis.
“Furthermore, diets deficient in choline and betaine were shown to directly affect histone and DNA methylation in a number animal models (Du et al., 2009; Mehedint et al., 2010; Niculescu et al., 2006), suggesting that alterations in exogenous methyl donor availability may have strong effects on cellular epigenetic state and thus contribute to tumorigenesis.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even TCA cycle intermediates are not solely used to produce NADH for mitochondrial respiration, but intermediates can also be used to form nonessential amino acids and fatty acids, which facilitate protein synthesis, membrane construction and cholesterol synthesis (206).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [206]
In the citing paper
“The PPP is chiefly used for NADPH and ribose synthesis to produce nucleotides (206).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [206]
In the citing paper
“However, not all tumors are glutamine dependent because some tumors and embryonic stem cells are capable of proliferation without an exogenous supply of glutamine, because they can synthesize it (206).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [206]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,346
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Self-citationHistone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Cited by
Sorted by citations
Items 101–200 of 1,029
SpaceM reveals metabolic states of single cells
Rappez, L., Stadler, M., Triana, S., Gathungu, R. M., Ovchinnikova, K., Phapale, P. B., Heikenwälder, M. F., & Alexandrov, T. (2021) · Nature Methods · doi:10.1038/s41592-021-01198-0 · Cited by 400
Nutrient acquisition strategies of mammalian cells
Palm, W., & Thompson, C. B. (2017) · Nature · doi:10.1038/nature22379 · Cited by 388
Self-citationLin, H., Liu, C., Hu, A.-K., Zhang, D., Yang, H., & Mao, Y. Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 462
3D microtumors in vitro supported by perfused vascular networks
Sobrino, A., Phan, D. T. T., Datta, R., Wang, X., Hachey, S. J., Romero-López, M., Gratton, E., Lee, A. P., George, S. C., & Hughes, C. C. W. (2016) · Scientific Reports · doi:10.1038/srep31589 · Cited by 387
Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment
Pérez‐Tomás, R., & Pérez-Guillén, I. (2020) · Cancers · doi:10.3390/cancers12113244 · Cited by 418
“At the same time, a decreased pHe creates the perfect environment for many of the acquired characteristics of cancers cells, in addition to facilitating tumor immune escape and effective proteolytic degradation of the ECM by invading tumor cells [33,34].”
BackgroundThe ERK and JNK pathways in the regulation of metabolic reprogramming
Papa, S., Choy, P. M., & Bubici, C. (2018) · Oncogene · doi:10.1038/s41388-018-0582-8 · Cited by 394
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Das, S., Dey, M. K., Devireddy, R. V., & Gartia, M. R. (2023) · Sensors · doi:10.3390/s24010037 · Cited by 471
The cancer epigenome: Concepts, challenges, and therapeutic opportunities
Dawson, M. A. (2017) · Science · doi:10.1126/science.aam7304 · Cited by 377
Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors
Andrejeva, G., & Rathmell, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.004 · Cited by 374
“However, excess NADH will suppress glycolysis, and the channeling of pyruvate into lactate can prevent this accumulation (Vander Heiden et al., 2009; Pavlova and Thompson, 2016).”
BackgroundInfluentialMetabolic Pathways Regulating Colorectal Cancer Initiation and Progression
La Vecchia, S., & Sebastián, C. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.018 · Cited by 349
Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo
Feyter, H. M. D., Behar, K. L., Corbin, Z. A., Fulbright, R. K., Brown, P. B., McIntyre, S., Nixon, T. W., Rothman, D. L., & de Graaf, R. A. (2018) · Science Advances · doi:10.1126/sciadv.aat7314 · Cited by 378
Wu, H., Han, Y., Sillke, Y. R., Deng, H., Siddiqui, S., Treese, C., Schmidt, F., Friedrich, M., Keye, J., Wan, J., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910698 · Cited by 384
“Reprogramming of metabolic pathways guarantees the viability and proliferative capacity of cancer cells in a nutrient-poor environment (Pavlova & Thompson, 2016).”
BackgroundLipid Droplets in Cancer: Guardians of Fat in a Stressful World
Petan, T., Jovičić, E. J., & Jusović, M. (2018) · Molecules · doi:10.3390/molecules23081941 · Cited by 379
“The changes in cancer metabolism are driven by oncogene activation or loss of tumour-suppressor genes, and by alterations in cellular signalling [2,92,93].”
BackgroundInfluentialSpatially resolved metabolomics to discover tumor-associated metabolic alterations
Sun, C., Li, T., Song, X., Huang, L., Zang, Q., Xu, J., Bi, N., Jiao, G., Hao, Y., Chen, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808950116 · Cited by 365
Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
Sun, L., Suo, C., Li, S., Zhang, H., & Gao, P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.005 · Cited by 374
The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics
Panigrahi, D. P., Praharaj, P. P., Bhol, C. S., Mahapatra, K. K., Patra, S., Behera, B. P., Mishra, S. R., & Bhutia, S. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.015 · Cited by 379
The metabolic landscape of RAS-driven cancers from biology to therapy
Mukhopadhyay, S., Vander Heiden, M. G., & McCormick, F. (2021) · Nature Cancer · doi:10.1038/s43018-021-00184-x · Cited by 315
Cotte, A. K., Aires, V., Fredon, M., Limagne, E., Dérangère, V., Thibaudin, M., Humblin, É., Scagliarini, A., de Barros, J.-P. P., Hillon, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02732-5 · Cited by 365
Harmon, C., Robinson, M. W., Hand, F., Almuaili, D., Mentor, K., Houlihan, D. D., Hoti, E., Lynch, L., Geoghegan, J., & O’Farrelly, C. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0481 · Cited by 384
“Lactate is produced by tumor cells during Warburg metabolism and is then exported via monocarboxylate transporters (MCT1/4) along with protons, lowering the extracellular pH (26).”
BackgroundSpatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation
Sivanand, S., Viney, I. A., & Wellen, K. E. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.11.004 · Cited by 374
“In addition to maintaining bioenergetics and supplying the building blocks and reducing equivalents needed for macromolecular biosynthesis, it is increasingly recognized that metabolites also play diverse signaling roles [1,2].”
BackgroundAltered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets
Bi, J., Chowdhry, S., Wu, S., Zhang, W., Masui, K., & Mischel, P. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0226-5 · Cited by 359
The Link Between Angiogenesis and Endothelial Metabolism
Potente, M., & Carmeliet, P. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105134 · Cited by 360
O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth
Nie, H., Ju, H., Fan, J., Shi, X., Cheng, Y., Cang, X., Zheng, Z., Duan, X., & Yi, W. (2020) · Nature Communications · doi:10.1038/s41467-019-13601-8 · Cited by 349
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
Peng, X., Chen, Z., Farshidfar, F., Xiaoyan, X., Lorenzi, P. L., Wang, Y., Cheng, F., Tan, L., Mojumdar, K., Du, D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.077 · Cited by 338
“…nucleotide, and vitamin & cofactor metabolism were consistently associated with poor prognosis (Figure 3B), compatible with the hypothesis that cancer cells have increased demands for glucose uptake and nucleotide synthesis (Pavlova and Thompson, 2016; Vander Heiden and DeBerardinis, 2017).”
BackgroundGenetically encoded fluorescent sensors reveal dynamic regulation of NADPH metabolism
Tao, R., Zhao, Y., Chu, H., Wang, A., Zhu, J., Chen, X., Zou, Y., Shi, M., Liu, R., Su, N., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4306 · Cited by 349
Bacteria in cancer initiation, promotion and progression
Tekle, G. E., & Garrett, W. S. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00594-2 · Cited by 361
Wang, F., Wang, K., Xu, W., Zhao, S., Ye, D., Wang, Y., Xu, Y., Zhou, L., Chu, Y., Zhang, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.065 · Cited by 340
Biomolecular Condensates and Cancer
Boija, A., Klein, I. A., & Young, R. A. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.003 · Cited by 338
“Metabolic reprogramming is a hallmark of malignancy; cancer cells adjust metabolic and nutrient acquisition to support growth and dissemination (Dayton et al., 2016; Vander Heiden, 2011; Hopkins et al., 2016; Martinez-Outschoorn et al., 2017; Pavlova and Thompson, 2016; Schulze and Harris, 2012; Shankaraiah et al., 20…”
BackgroundSun, C., Wang, A., Zhou, Y., Chen, P., Wang, X., Huang, J., Gao, J., Wang, X. D., Shu, L., Lu, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38360-5 · Cited by 352
Mullarky, E., Lucki, N. C., Beheshti Zavareh, R., Anglin, J. L., Gomes, A. P., Nicolay, B. N., Wong, J. C. Y., Christen, S., Takahashi, H., Singh, P. K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521548113 · Cited by 333
Metabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer
Sciacovelli, M., & Frezza, C. (2017) · FEBS Journal · doi:10.1111/febs.14090 · Cited by 334
Qing, Y., Dong, L., Gao, L., Li, C., Li, Y., Han, L., Prince, E. A., Tan, B., Deng, X., Wetzel, C., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.026 · Cited by 328
“An emerging hallmark of cancer is reprogramming of cellular metabolism (Hanahan and Weinberg, 2000, 2011; Hsu and Sabatini, 2008; Pavlova and Thompson, 2016).”
Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
Netea-Maier, R. T., Smit, J. W. A., & Netea, M. G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.037 · Cited by 333
“The tumor cell metabolism is therefore characterized by an increased glucose consumption, reflected by the upregulation of the glucose transporter (GLUT1) at the surface of the tumor cells, their increased glucose uptake and oxygen consumption [20,21].”
Metabolic Codependencies in the Tumor Microenvironment
Dey, P., Kimmelman, A. C., & DePinho, R. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1211 · Cited by 349
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers
Villa, G. R., Hulce, J. J., Zanca, C., Bi, J., Ikegami, S., Cahill, G. L., Gu, Y., Lum, K. M., Masui, K., Yang, H., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.008 · Cited by 332
“De novo cholesterol synthesis consumes 26 reducing equivalents of nicotinamide adenine dinucleotide phosphate (NADPH) (Lunt and Vander Heiden, 2011), and it is tempting to speculate that the reliance of GBM cells on CNS-derived cholesterol enables them to direct their cellular NADPH, a key reducing agent in relatively…”
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 356
“Histone acetylation is easily affected by cellular signaling and the nutrition status of cells [66].”
BackgroundMetabolic origins of spatial organization in the tumor microenvironment
Carmona‐Fontaine, C., Déforet, M., Akkari, L., Thompson, C. B., Joyce, J. A., & Xavier, J. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700600114 · Cited by 335
“Herewerevealthatgradientsofmetabolites,formedbythe alteredmetabolismofcancercells(16–18)andaccentuatedbyaberrantvascularization(11,19–21),leadtopredictablephe-notypicdiversityinthetumormicroenvironment.”
Self-citationThe tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
Lim, A. R., Rathmell, W. K., & Rathmell, J. C. (2020) · eLife · doi:10.7554/elife.55185 · Cited by 336
Metabolic signatures of cancer cells and stem cells
Intlekofer, A. M., & Finley, L. W. S. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0032-0 · Cited by 322
Mitochondria and cancer chemoresistance
Guerra, F., Arbini, A., & Moro, L. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.012 · Cited by 331
Mukhopadhyay, S., Goswami, D., Adiseshaiah, P. P., Burgan, W., Yi, M., Guerin, T. M., Kozlov, S. V., Nissley, D. V., & McCormick, F. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1363 · Cited by 279
“Oncogene-directed metabolic reprogramming is an emerging hallmark in cancer (6, 7).”
BackgroundHyaluronan: Metabolism and Function
Kobayashi, T., Chanmee, T., & Itano, N. (2020) · Biomolecules · doi:10.3390/biom10111525 · Cited by 321
“Metabolic reprogramming has emerged as a critical determinant of malignant cells [120,121].”
BackgroundTumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review
Thakkar, S., Sharma, D., Kalia, K., & Tekade, R. K. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.009 · Cited by 321
Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
Chen, A.-N., Luo, Y., Yang, Y.-H., Fu, J.-T., Geng, X.-M., Shi, J.-P., & Yang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688910 · Cited by 324
“In addition, in the conversion of pyruvate to lactate, because of NAD regeneration, the maintenance of glycolysis is dependent on preservation of the NAD/NADH ratio (13, 14).”
BackgroundCancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells
Zhao, Y., Ye, X., Xiong, Z., Ihsan, A., Arés, I., Martínez, M., López-Torres, B., Martínez‐Larrañaga, M., Anadón, A., Wang, X., et al. (2023) · Metabolites · doi:10.3390/metabo13070796 · Cited by 347
“In recent years, it has been discovered that there are six major markers of cancer-related metabolic changes, mainly involving the interaction of nutrient uptake, biosynthesis, energy metabolism, and the tumor microenvironment [21].”
BackgroundDrosophila melanogaster: A Model Organism to Study Cancer
Mirzoyan, Z., Sollazzo, M., Allocca, M., Valenza, A., Grifoni, D., & Bellosta, P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00051 · Cited by 348
Glycogen accumulation and phase separation drives liver tumor initiation
Liu, Q., Li, J., Zhang, W., Xiao, C., Zhang, S., Nian, C., Li, J., Su, D., Chen, L., Zhao, Q. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.10.001 · Cited by 313
Tumor microenvironment in glioblastoma: Current and emerging concepts
Sharma, P., Aaroe, A., Liang, J., & Puduvalli, V. K. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad009 · Cited by 372
Metabolic interventions in the immune response to cancer
O’Sullivan, D., Sanin, D. E., Pearce, E. J., & Pearce, E. L. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0140-9 · Cited by 320
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
Ramchandani, D., Berisa, M., Tavarez, D. A., Li, Z., Miele, M. M., Bai, Y., Lee, S. B., Ban, Y., Dephoure, N., Hendrickson, R. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27559-z · Cited by 317
Targeting amino acid metabolism for cancer therapy
Lukey, M. J., Katt, W. P., & Cerione, R. A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.12.003 · Cited by 293
“Indeed, glucose and then glutamine are the most rapidly consumed nutrients by many cultured cancer cell lines [4,5], although altered metabolism of fatty acids, acetate, nucleotides, folate, proteins and several amino acids besides glutamine has also been reported [1].”
BackgroundThe Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity
Chavez-Dominguez, R., Perez-Medina, M., López-González, J. S., Galicia-Velasco, M., & Aguilar‐Cázares, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.578418 · Cited by 322
“Consequently, the current research focus on metabolic reprogramming on the development and progression of human cancers reflects these hallmarks of cancer (5, 50).”
BackgroundCrosstalk between glucose metabolism, lactate production and immune response modulation
Ye, L., Jiang, Y., & Zhang, M. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.11.001 · Cited by 326
Tumor suppressor p53 and metabolism
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy070 · Cited by 313
“Tumor suppressor p53 Metabolic reprogramming is a hall marker of cancer cells, which plays a pivotal role in cancer progression by providing energy and a wide variety of substrates for biosynthesis to support the rapid proliferation and survival of cancer cells (Cairns et al., 2011; Pavlova and Thompson, 2016; Wolpaw…”
BackgroundSlow TCA flux and ATP production in primary solid tumours but not metastases
Bartman, C. R., Weilandt, D. R., Shen, Y., Lee, W. D., Han, Y., TeSlaa, T., Jankowski, C. S. R., Samarah, L., Park, N. R., da Silva-Diz, V., et al. (2023) · Nature · doi:10.1038/s41586-022-05661-6 · Cited by 299
Proline Metabolism in Cell Regulation and Cancer Biology: Recent Advances and Hypotheses
Phang, J. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7350 · Cited by 302
“A special role for proline in metabolic regulation is now accepted (3, 67, 72), and recent work not only showed that proline metabolism is critical in cancer reprogramming (22, 48, 86) but also established its clinical relevance (17).”
BackgroundMetabolism shapes the tumor microenvironment
Reina‐Campos, M., Moscat, J., & Díaz-Meco, M. T. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.05.006 · Cited by 292
Ilhan, Z. E., Łaniewski, P., Thomas, N., Roe, D. J., Chase, D. M., & Herbst‐Kralovetz, M. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.028 · Cited by 302
“…revealed multiple emerging hallmarks of cancer in cervical carcinogenesis, including abnormalities in nitrogen and energy metabolism, increased cellular proliferation due to changes in amino acid and carbohydrate fl uxes, and dysbiotic microbiota and host-microbe co-metabolism [33,82].”
InfluentialNuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination
Sivanand, S., Rhoades, S., Jiang, Q., Lee, J. V., Benci, J., Zhang, J., Yuan, S., Viney, I., Zhao, S., Carrer, A., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.008 · Cited by 295
“Nutrient uptake and utilization are altered in cancer cells in response to oncogenic signaling to promote macromolecular biosynthesis, survival, growth, and proliferation (DeBerardinis and Chandel, 2016; Pavlova and Thompson, 2016).”
BackgroundExercise-dependent regulation of the tumour microenvironment
Koelwyn, G. J., Quail, D. F., Zhang, X., White, R. M., & Jones, L. W. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.78 · Cited by 307
Ericksen, R. E., Lim, S. L., McDonnell, E., Shuen, W. H., Vadiveloo, M. K., White, P. J., Ding, Z., Kwok, R., Lee, P., Radda, G. K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.020 · Cited by 302
“Introduction 26 The metabolic reprogramming of cancer has been observed for decades (Pavlova and Thompson, 2016; 27 Vander Heiden et al., 2009), yet whether this reprogramming is a general aspect of proliferation, an unintended 28”
BackgroundArginine reprograms metabolism in liver cancer via RBM39
Mossmann, D., Müller, C., Park, S., Ryback, B. M., Colombi, M., Ritter, N., Weißenberger, D., Dazert, E., Coto‐Llerena, M., Nuciforo, S., et al. (2023) · Cell · doi:10.1016/j.cell.2023.09.011 · Cited by 309
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase
Wang, Z., & Dong, C. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.11.003 · Cited by 300
Jiang, Y., Mao, C., Yang, R., Yan, B., Shi, Y., Liu, X., Lai, W., Liu, Y., Wang, X., Xiao, D., et al. (2017) · Theranostics · doi:10.7150/thno.19988 · Cited by 298
“Reprogramming of cellular metabolism, including the regulation of apoptotic and necrotic cell death, is necessary for tumorigenesis [1-3].”
BackgroundBecker, L. M., O’Connell, J. T., Vo, A. P., Cain, M. P., Tampe, D., Bizarro, L., Sugimoto, H., McGow, A. K., Asara, J. M., Lovisa, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107701 · Cited by 296
“Enhanced glycolysis supports the increased demand for biosynthetic products necessary for cancer cell growth and multiplication (Pavlova and Thompson, 2016; Vander Heiden and DeBerardinis, 2017).”
BackgroundTranssulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation
Zhu, J., Berisa, M., Schwörer, S., Qin, W., Cross, J. R., & Thompson, C. B. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.009 · Cited by 292
“Amino acid acquisition is a critical component of the cellular metabolic network, because amino acids not only function as building blocks for protein translation, but also support various other metabolic processes such as nucleotide synthesis and redox homeostasis (Pavlova and Thompson, 2016).”
BackgroundSelf-citationCarbonic Anhydrases: Role in pH Control and Cancer
Mboge, M. Y., Mahon, B. P., McKENNA, R. V., & Frost, S. C. (2018) · Metabolites · doi:10.3390/metabo8010019 · Cited by 297
“This ultimately sets up conditions that benefit tumor cell survival and proliferation, resulting in an unfavorable prognosis for cancer patients [67,76,78,81].”
BackgroundBreast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis
Christen, S., Lorendeau, D., Schmieder, R., Broekaert, D., Metzger, K., Veys, K., Elia, I., Buescher, J. M., Orth, M. F., Davidson, S. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.042 · Cited by 258
“Most proliferating cells, such as cancer cells, exploit the tricarboxylic acid (TCA) cycle for biomass precursor production (Pavlova and Thompson, 2016), a process that is critically Cell This is an open access article under the CC BY-N dependent on sufficient anaplerosis.”
BackgroundThe Influence of Metabolism on Drug Response in Cancer
Zaal, E. A., & Berkers, C. R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00500 · Cited by 272
“AN, 6-aminonicotinamide; ATP, adenosine triphosphate; BSO, buthionine sulfoximine; CPT1, carnitine palmitoyl transferase 1; DCA, dichloroacetate; ETC, electron transport chain; FASN, fatty acid synthase; FH, fumarate hydratase; G6PD, glucose-6-phosphate dehydrogenase; GCLC, glutathione cysteine ligase; GLS, glutaminas…”
BackgroundInfluentialYu, L., Lu, M., Jia, D., Ma, J., Ben‐Jacob, E., Levine, H., Kaipparettu, B. A., & Onuchic, J. N. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2074 · Cited by 272
“Note that, in addition to the use of glycolysis and OXPHOS, cancer cells can also utilize glutamine as a nitrogen source (5), while cancer-associated fibroblasts can perform glycolysis to fuel cancer cells byproducing lactate, knownas reverseWarburg effects (50).”
BackgroundLactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
Mishra, D., & Banerjee, D. (2019) · Cancers · doi:10.3390/cancers11060750 · Cited by 277
“Cancer cells establish increased metabolic interactions by utilizing opportunistic modes for nutrient acquisition by differential uptake of glucose and amino acids [3] as well as increase in lipids, proteins and nucleic acid biosynthesis for growth [4].”
BackgroundXu, X., Qiu, P., Jiang, X., Tan, S., Yang, Y., Yang, W., Han, Y., Chen, Y., Oyang, L., Lin, J., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01020-1 · Cited by 293
Jia, D., Park, J. E., Jung, K., Levine, H., & Kaipparettu, B. A. (2018) · Cells · doi:10.3390/cells7030021 · Cited by 283
“Due to the enhanced understanding of the importance and variability of cancer metabolism, metabolic reprogramming has attained the status of a hallmark of cancer [5,6].”
BackgroundMechanisms driving the immunoregulatory function of cancer cells
van Weverwijk, A., & de Visser, K. E. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-022-00544-4 · Cited by 288
Endothelial cell metabolism in health and disease: impact of hypoxia
Wong, B. W., Marsch, E., Treps, L., Baes, M. I., & Carmeliet, P. (2017) · The EMBO Journal · doi:10.15252/embj.201696150 · Cited by 286
“Anaplerosis is the process where glucose, glutamine or amino acids replenish the TCA cycle (Pavlova & Thompson, 2016).”
BackgroundTan, Z., Xiao, L., Tang, M., Bai, F., Li, J., Li, L., Shi, F., Li, N., Li, Y., Du, Q., et al. (2018) · Theranostics · doi:10.7150/thno.21451 · Cited by 279
“Cancer cells depend on alternative metabolic pathways to acquire nutrients and produce building blocks or energy for survival [11-13].”
BackgroundLissanu, Y., Sun, Y., Terranova, C. J., Khan, F., Martínez-Ledesma, E., Gay, J. P., Gao, G., Mullinax, R. A., Khor, T. O., Feng, N., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0019-5 · Cited by 268
Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology
Kumar, S., & Lombard, D. B. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1458071 · Cited by 273
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Jyotsana, N., Ta, K. T. L., & DelGiorno, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858462 · Cited by 290
“Under certain nutrient deficient conditions, cancer cells undergo cell death whereas normal healthy cells survive because they are more metabolically flexible (45, 46).”
BackgroundRole of tumor and host autophagy in cancer metabolismPreprint
Poillet-Perez, L., & White, E. (2019) · Genes & Development · doi:10.1101/gad.325514.119 · Cited by 273
“Tumors obtain their entire nutrient supply from the host to fuel these pathways (DeBerardinis and Chandel 2016; Pavlova and Thompson 2016; Vander Heiden and DeBerardinis 2017).”
BackgroundCancer stem cells (CSCs): metabolic strategies for their identification and eradication
Francesco, E. M. D., Sotgia, F., & Lisanti, M. P. (2018) · Biochemical Journal · doi:10.1042/bcj20170164 · Cited by 274
L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH
Intlekofer, A. M., Wang, B., Liu, H., Shah, H., Carmona-Fontaine, C., Rustenburg, A. S., Salah, S., Gunner, M. R., Chodera, J. D., Cross, J. R., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2307 · Cited by 268
Self-citationThe role of lipid metabolic reprogramming in tumor microenvironment
Yang, K., Wang, X., Song, C., Zhao, H., Wang, R., Xu, Y., Jiang, G., Wan, Y., Mei, J., & Mao, W. (2023) · Theranostics · doi:10.7150/thno.82920 · Cited by 311
“Finally, alterations in metabolism have long-term effects on the tumor and immune cells in the TME [21].”
Tumor Microenvironment, Metabolism, and Immunotherapy
DeBerardinis, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmcibr1914890 · Cited by 266
Wu, H., Liu, B., Chen, Z., Li, G., & Zhang, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2426-z · Cited by 267
Song, X., Liu, J., Kuang, F., Chen, X., Zeh, H. J., Kang, R., Kroemer, G., Xie, Y., & Tang, D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108767 · Cited by 262
Jiang, J., Huang, D., Jiang, Y., Hou, J., Tian, M., Li, J., Sun, L., Zhang, Y., Zhang, T., Li, Z., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.647559 · Cited by 274
“Disorders in cellular metabolism have been linked to the pathobiology of several common respiratory diseases and lung cancer (7); aberrantly activated pathways and genes, such as PI3K/Akt/mTOR, RAS/RAF and cMYC, accelerate glucose and glutamine metabolism to meet the need of energy and building blocks for lung cancer…”
BackgroundThe complexity of p53-mediated metabolic regulation in tumor suppression
Liu, Y., & Gu, W. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.010 · Cited by 267
Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot
Goberdhan, D. C. I., WILSON, C. G., & Harris, A. L. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.013 · Cited by 257
A guide to 13C metabolic flux analysis for the cancer biologist
Antoniewicz, M. R. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0060-y · Cited by 278
Mishra, C. B., Tiwari, M., & Supuran, C. T. (2020) · Medicinal Research Reviews · doi:10.1002/med.21713 · Cited by 272
“with a high tumor grade, treatment upshot and poor prognosis in lung, breast, brain, esophageal, gastric, and cervix cancers.(51,52) Investigations indicate that CA IX expression correlates with other prognostic factors, such as EGFR, MUC‐1, p53, and p300.”
BackgroundDucker, G. S., Ghergurovich, J. M., Mainolfi, N., Suri, V., Jeong, S. K., Hsin-Jung Li, S., Friedman, A., Manfredi, M. G., Gitai, Z., Kim, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706617114 · Cited by 261
“C growth and proliferation are supported by metabolic changes, including enhanced glucose uptake, aerobic glycolysis (the Warburg effect), and folate-dependent one-carbon (1C) metabolism (1, 2).”
BackgroundMichaudel, C., Danne, C., Agus, A., Magniez, A., Aucouturier, A., Spatz, M., Lefèvre, A., Kirchgesner, J., Rolhion, N., Wang, Y., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327337 · Cited by 281
An Overview of Cancer Treatment Modalities
Abbas, Z., & Rehman, S. (2018) · InTech eBooks · doi:10.5772/intechopen.76558 · Cited by 297
“The microenvironment of benign tumor manifests dysregulation of various regulatory proteins and extracellular environment which plays a vital role in origination and development of cancers [3].”
BackgroundLiao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.12.003 · Cited by 299
Yasuda, T., & Wang, Y. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.03.008 · Cited by 278
Zhang, C., Wang, X., Zhang, P., He, T.-C., Han, J.-H., Zhang, R., Lin, J., Fan, J., Lu, L., Zhu, W.-W., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04506-4 · Cited by 273
“The metabolic adaptation of cancer cells is necessary for their proliferation, adaption to tumor microenvironment and distant metastasis [13, 14].”
Lüscher, B., Bütepage, M., Eckei, L., Krieg, S., Verheugd, P., & Shilton, B. H. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00122 · Cited by 264
Möckl, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00253 · Cited by 260
Metadata
- Authors
- Pavlova, N. N., & Thompson, C. B.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Thompson, Craig B.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 23
- Issue
- 1
- Pages
- 27-47
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4715268
- OpenAlex
- W2234115940
- Semantic Scholar
- 1e8b6414a84ad7a310eeee976435e51a609d3979
- Cited by
- 5,926
- References
- 254
- Citations by year
- 2026: 576 · 2025: 556 · 2024: 661 · 2023: 678 · 2022: 819 · 2021: 846 · 2020: 601 · 2019: 477 · 2018: 352 · 2017: 252 · 2016: 103
- FWCI
- 36.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 377 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute
- Terri Brodeur Breast Cancer Foundation
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, carcinogenesis, glucose uptake, amino acid uptake, nutrient acquisition, glycolysis, TCA cycle intermediates, NADPH production, nitrogen requirements, tumor microenvironment, tumor classification
- MeSH terms
- Animals, Antineoplastic Agents, Biological Transport, Cell Transformation, Neoplastic, Energy Metabolism, Humans, Mutation, Neoplasms, Signal Transduction, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review